Physician

Rocky Lynn Mcadams, MD

According to 2025 Medicare claims, Rocky Mcadams, MD (NPI: 1740442607) practices ophthalmology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is EYE MEDICIAL ASSOCIATES OF ABILENE (NPI: 1043325996; TIN: 751531889) and primary practice location at 79606-5211. Mcadams is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mcadams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,784 traditional Medicare patients, billed 5,520 HCPCS/CPT codes, and received $654,743 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 3,955 prescription claims across 1,277 beneficiaries totaling $243,712 in drug costs, led by Difluprednate (Difluprednate). DME data shows 55 claims. Open Payments data shows 14 records totaling $2,734. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $407,859 to $654,743. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,056	2,786	$407,859
2016	1,050	3,002	$409,404
2017	1,282	3,801	$522,722
2018	1,691	5,097	$704,437
2019	1,840	5,506	$745,612
2020	1,498	4,351	$550,534
2021	1,680	4,931	$613,657
2022	1,804	5,207	$631,906
2023	1,890	5,645	$688,053
2024	1,784	5,520	$654,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	487	1,713	$229,086
2016	458	1,705	$212,681
2017	489	1,678	$222,280
2018	467	1,583	$210,444
2019	970	3,118	$385,817
2020	857	3,050	$355,836
2021	875	2,810	$300,218
2022	932	3,027	$291,384
2023	1,130	3,676	$311,761
2024	1,277	3,955	$243,712

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	95	98	$5,549
2016	55	55	$2,817
2017	30	31	$1,325
2018	80	81	$4,222
2019	46	57	$3,604
2020	40	52	$2,913
2021	16	16	$748
2022	55	55	$3,337
2023	72	72	$4,223
2024	55	55	$3,343

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	700	1,161	$333
92014	Established patient complete exam of visual system	593	596	$76
92012	Established patient problem focused exam of visual system	315	350	$58
92002	New patient problem focused exam of visual system	509	509	$53
92136	Measurement of corneal curvature and depth of eye	851	1,924	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Difluprednate	Difluprednate	739	15,450	$67,975
Moxifloxacin	Moxifloxacin Hcl	1,353	23,841	$30,532
Lumigan	Bimatoprost	84	2,898	$22,808
Restasis	Cyclosporine	22	900	$18,460
Vyzulta	Latanoprostene Bunod	44	2,081	$17,389

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	21	21	$1,887
V2020	Frames, purchases	N	34	34	$1,456

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$2,734	Carl Zeiss Meditec USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rocky Lynn Mcadams, MD?

Tedicare shows public-source Medicare data for Rocky Lynn Mcadams, MD (NPI 1740442607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rocky Lynn Mcadams, MD have ACO affiliation data?

Rocky Lynn Mcadams, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rocky Lynn Mcadams, MD?

Rocky Lynn Mcadams, MD is linked to EYE MEDICIAL ASSOCIATES OF ABILENE (billing NPI 1043325996) in the available physician profile data.

Does Rocky Lynn Mcadams, MD have Open Payments data?

Rocky Lynn Mcadams, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.